Provider of high performance, ultra secure network platform to provide remote medical equipment access and control for telemedicine, as well as secure medical records transfers. We empower societies with trusted, secure, private communications. Works with any legacy software with no changes required.
VUNO
VUNO is widely recognized as a pioneer in AI-based medical solution technologies, offering a specialized portfolio that includes biosignal solutions like VUNO Med®-DeepCARS® and medical imaging solutions such as VUNO Med®-DeepBrain™ and VUNO Med®-Chest X-ray™. | VUNO, founded in 2014, is a leading medical AI company. Leveraging cutting-edge AI technology, VUNO analyzes a wide range of medical data—from bio signals such as ECG, respiratory rate, and blood pressure to medical images including X-rays and fundus images—to predict critical events and support clinicians in decision-making. Committed to patient-centered innovation, VUNO strives to make high-quality healthcare accessible to everyone, worldwide.
V5med Inc.
V5 Lung AI & Digital Platform leverages low-dose CT and advanced AI algorithms to enable accurate lung nodule detection and early lung cancer identification. The platform integrates seamlessly into clinical workflows to improve efficiency and support scalable screening programs.
TeraRecon / ConcertAI
TeraRecon is a ConcertAI solution provider for AI-empowered radiology, oncology, cardiology, neurology, and more. Serving ~1,900 clinical sites globally, TeraRecon, is a Best in KLAS solution provider for AI-empowered radiology, oncology, cardiology, neurology, and vascular surgery. Awarded the KLAS Category Leader for Advanced Visualization, TeraRecon solutions are independent of any one manufacturer’s imaging equipment or PACS system, allowing a single, unified, and simplified clinical workflow that can improve efficiencies and deliver actionable physician-guided insights. | TeraRecon is ConcertAI’s imaging solutions for AI-empowered radiology, oncology, cardiology, neurology, and more. Serving ~2,000 clinical sites globally, TeraRecon solutions, automate insights and improve patient care with clinical AI and workflows. Awarded the KLAS Category Leader for Advanced Visualization, TeraRecon solutions are independent of any one manufacturer’s imaging equipment or PACS system, allowing a single, unified, and simplified clinical workflow that can improve efficiencies and deliver actionable physician-guided insights.Â
TaiHao Medical Inc
Taihao Medical designs and develops AI medical software to help healthcare providers manage the increasing workloads. We focus on breast screening & diagnostic solution by utilizing ultrasound and LDCT AI solutions for lung disease. Our leading products include: 1.BR-FHUSTM Smart System (Free-Hand ABUS): AI for ultrasound breast screening 2.BR-ViewerTM for ABUS 3.BU-CADTM Decision Support: AI for ultrasound breast cancer diagnosis 4.Ti–LUNGTM Decision Support: AI for LDCT lung cancer screening & diagnosis Leading technology & expertise include: 1.Real-Time AI detects suspicious areas in Ultrasound images 2.Advisory Board include scientists & physicians in Taiwan, Japan, China, and USA We have received US FDA, Japan’s PMDA, Taiwan’s TFDA, China’s NMPA, and more than 10 patent licenses. We not only advocate our products to the world, integrate with AI marketplace, but also cooperate with government’s screening program, women breast centers, mammography clinics, insurance companies and ultrasound machine manufacturers. Taihao Medical’s shareholders include CDIB Capital Healthcare Ventures Limited, Japan ＣＥＳデカルト, Top Taiwan Venture Capital Co., Ltd. and CTBC Securities Venture Capital Co., Ltd., who are involved in our capital investing. We strive for integrating our AI products in different types of ultrasound devices. Furthermore, global market expansion has been one of our key landmarks for the past and upcoming years, supported by our strong technical team in related areas. They are highly professional and well experienced. “Early Detection, Early Treatment, Most Lives Saved” is Taihao’s Value Proposition. We aim to be one of the most successful AI Medical companies worldwide. Welcome to follow our Linkedin and notice our continuous milestone, the latest news, and employees’ life in Taihao Medical.
SPIE – The Intl. Society for Optics and Photonics
SPIE, the international society for optics and photonics, brings engineers, scientists, students, and business professionals together to advance light-based science and technology. Founded in 1955, SPIE engages our global constituency through industry-leading conferences and exhibitions; publications of conference proceedings, books, and journals in the SPIE Digital Library; and career-building opportunities. | The Journal of Medical Imaging (JMI) publishes peer-reviewed communication and archiving of fundamental and translational research, as well as applications, focused on medical imaging, a field that continues to benefit from technological improvements and yield biomedical advancements in the early detection, diagnostics, and therapy of disease, as well as in the understanding of normal conditions.
SIMCO Electronics
SIMCO Electronics is a leading provider of calibration and software services for test and measurement instruments used in technology organizations. Founded in 1962 to service NASA and high technology firms in Silicon Valley, SIMCO is committed to providing the highest level of quality and customer service in the industry. Today SIMCO’s 20 calibration labs and its CERDAAC software serve over 3,000 organizations, including 16 of the top 20 global biomedical device manufacturers and 14 of the top 20 global aerospace and defense manufacturers.
Riverain Technologies
At Riverain, we are relentless innovators that empower healthcare providers by streamlining diagnostic processes, elevating detection accuracy, and improving the outcomes of patients with cardiothoracic diagnoses. As imaging volume continues to grow along with the demand for faster turnaround times and earlier diagnoses, tools that improve efficiency and accuracy are essential. ClearRead™ Chest is a cardiothoracic AI suite that reduces reading time and eases cognitive burden while improving accuracy. A series of advanced AI algorithms are deployed and provide key insights and metrics on pulmonary nodules and CAC. Findings and analysis are then integrated in the radiology report. ClearRead is a valuable additional to lung cancer screening programs or for incidental nodule detection and CAC quantification.